A globally-oriented pharmaceutical manufacturer operating with integrated in-house development and supply chain capabilities for pharmaceutical products. The company offers over 180 medicines across more than 10 dosage forms (tablets, capsules, powders, drops, inhalers, patches, eye-drops) and serves markets in more than 80 countries. Its manufacturing network includes a European production site with EU batch testing and release of pharmaceutical products, and a specialised facility in India for high-potency drugs under a GMP-compliant environment.

This pharmaceutical company is a leading manufacturer and exporter with operations spanning over 160 countries, specializing in the development, production, and sale of high-quality generic pharmaceuticals for human use. They have a strong track record of success, having received numerous awards and distinctions including the "European Award for Best Practices" . The company's extensive product portfolio encompasses a wide range of dosage forms and therapy areas, with specific details on these areas, forms, GMP certifications, and patents not provided in the text. Their focus extends beyond prescription medications to include over-the-counter drugs and potentially medical devices or supplements as well.

This global pharmaceutical company is dedicated to improving patients' lives through high-quality, differentiated products and services. They leverage a collaborative network to achieve success in key regions like the EU and North America. Their focus areas include women's health, infectious diseases, and potentially other therapeutic areas based on their recent approvals and launches. They produce prescription medications (including injectables) and tablets, demonstrating expertise in various dosage forms. The company holds GMP certifications and boasts successful product patents, solidifying its commitment to quality and innovation.